Michelle Renee Griffin
Director · 3 filings · Latest: Mar 11, 2026
Adaptive Biotechnologies Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADPT | Michelle Renee Griffin | Director | Mar 11, 2026 | Sale | $13.91 | 15,394 | $214.1K | 15,625 | |
ADPT | MICHELLE GRIFFIN | — | Mar 11, 2026 | Proposed Sale | $13.91 | 15,394 | $214.1K | — | |
ADPT | Michelle Renee Griffin | Director | Mar 3, 2026 | Sale | $15.30 | 48,044 | $735.1K | 15,394 | |
ADPT | Michelle Renee Griffin | Director | Mar 3, 2026 | Option Exercise | $3.99 | 48,044 | $191.7K | 63,438 | |
ADPT | MICHELLE GRIFFIN | — | Mar 3, 2026 | Proposed Sale | $16.12 | 48,044 | $774.5K | — | |
ADPT | GRIFFIN MICHELLE RENEE | — | Mar 13, 2025 | Proposed Sale | $7.19 | 36,291 | $260.9K | — | |
ADPT | MICHELLE GRIFFIN | — | Mar 6, 2025 | Proposed Sale | $7.94 | 15,664 | $124.4K | — |